Across the country, states are grappling with an array of different regulatory strategies, overseen by different agencies, to address drugs prescribed to workers for their injuries.

This report provides policymakers and system stakeholders with a basic understanding of the different strategies adopted by all 50 states and the District of Columbia, and points to the regulations for those seeking more detail.

It also provides information on some of the most prominent prescription drug issues stakeholders are concerned about today, such as the following:

  • Rules for Limiting and Monitoring Opioid Prescriptions
  • Medical Marijuana Regulations
  • Workers’ Compensation Drug Formularies
  • Prescription Drug Monitoring Programs
  • Price Regulations for Pharmacy- and Physician-Dispensed Drugs
  • Drug Testing Regulations

The tables in this report were compiled from completed surveys of two agencies for each of the 50 states and the District of Columbia as of January 1, 2020.

Workers’ Compensation Prescription Drug Regulations: A National Inventory, 2020. Karen Rothkin with the assistance of Elizabeth Hopkins. June 2020. WC-20-26.

Video: